Data Sheet 1_Secretoneurin plasma levels are decreased after catheter ablation for atrial fibrillation—patients with AF produce lower SN levels than healthy individuals: the SAFE r... حسب Jiří Plášek (21805048)

"…Background<p>Secretoneurin (SN) is a neuropeptide that counterbalances disorders of cell calcium cycling via calmodulin and thus may be involved in arrhythmogenesis. …"

Primary monocytes at 1 x 10⁶ cells were seeded in a flask and supplemented with RPMI 1640 + GM-CSF + IL-4 and incubated at 37°C for 6 days for monocyte to macrophage tra... حسب Janani Madhuravasal Krishnan (19736002)

Principal coordinates analysis (PCoA). حسب Wararak Choovanichvong (22110371)

"…Analysis of bacterial abundance revealed a shift in trends as the disease combined from control to NSESKD and SESKD group, respectively, across 7 genera: <i><i>Actinobacillus</i></i>, <i>TM7x</i>, <i><i>Capnocytophaga</i></i>, <i><i>Neisseria</i></i>, and <i><i>Leptotrichia</i></i> increased in abundance, while <i><i>Actinomyces</i></i> and <i><i>Atopobium</i></i> decreased. …"

Proportion of time spent in the Start Room or Avoidance Room or showing a behaviour (Stimulus Contact) presented across stimuli and separately for female (n = 10) and male (n = 10)... حسب Sara Hintze (3216885)

Initial participants by wave*. حسب Yeo Ju Sohn (18536198)

"…<div><p>Background</p><p>Diabetes mellitus (DM) is a significant public health concern, particularly in the elderly population. …"

General characteristics of research participants. حسب Yeo Ju Sohn (18536198)

"…<div><p>Background</p><p>Diabetes mellitus (DM) is a significant public health concern, particularly in the elderly population. …"

Clinical data of the control and CoA cases in our cohort. حسب Inmaculada Villanueva-Baxarias (21454246)

Table2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX حسب Sofia Schaeffer (20379954)

"…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …"

Table1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX حسب Sofia Schaeffer (20379954)

"…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …"

Deaths and ASMR of AA^a due to Hypertension in 1990 and 2021, along with the EAPC from 1990 to 2021. حسب Guanghui Yu (423945)

The trends in ASDR of hypertension-related AA by sex from 2022 to 2050 using the BAPC (A) Female; (B) Male. حسب Guanghui Yu (423945)

S1 File - Effectiveness of a school-based physical activity intervention on overweight and obesity among children and adolescents in Pakistan حسب Moazzam Tanveer (20775814)

Comparison of ν_s measured and predicted estimates of the optimized GPR approach for (a) training, (b) validation, and (c) testing datasets. حسب Fahd Saeed Alakbari (10701871)

Original data (a, b, c, d) and disproportionality analysis results (ROR & IC). حسب Mengsi Peng (12882734)

SEM images (a) 5LZCM (b) 10LZCM (c) 15LZCM. حسب Md. Abu Daud (21485629)

Data. حسب Aroon La-up (14095691)

"…This study found a statistically significant decrease in BMD in the group with the lowest U-Cd levels (<2.0 μg/g creatinine, p = 0.001) and in the overall sample (from 0.392 ± 0.079 μg/g creatinine in 2019 to 0.384 ± 0.094 μg/g creatinine in 2022, p = 0.004). …"

Forest plot showing the ratio of odds of acute side effects: nausea (a) and vomiting (b) (=events) among pediatric patients with brain tumors treated with PT or XRT. حسب Renáta Kiss-Miki (20760127)

Morphologic changes after dihydrotestosterone (DHT) treatment.1A: Diffuse lobular atrophy (20x). حسب Jinho Lee (587173)

A set of 4 criteria for the needs of multi-criteria evaluation ‐ combinations B1– B5. حسب Roman Vavrek (13200141)

A set of 3 criteria for the needs of multi-criteria evaluation ‐ combinations C1–C10. حسب Roman Vavrek (13200141)